FI66880C - Foerfarande foer framstaellning av ett terapeutiskt anvaendbart till 16alfa-metylpregnan-serien hoerande nytt halogenderivat - Google Patents

Foerfarande foer framstaellning av ett terapeutiskt anvaendbart till 16alfa-metylpregnan-serien hoerande nytt halogenderivat Download PDF

Info

Publication number
FI66880C
FI66880C FI802092A FI802092A FI66880C FI 66880 C FI66880 C FI 66880C FI 802092 A FI802092 A FI 802092A FI 802092 A FI802092 A FI 802092A FI 66880 C FI66880 C FI 66880C
Authority
FI
Finland
Prior art keywords
compound
methyl
halogenderivat
metylpregnan
hoerande
Prior art date
Application number
FI802092A
Other languages
English (en)
Finnish (fi)
Other versions
FI802092A (fi
FI66880B (fi
Inventor
Jean-Georges Teutsch
Roger Deraedt
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI802092A publication Critical patent/FI802092A/fi
Application granted granted Critical
Publication of FI66880B publication Critical patent/FI66880B/fi
Publication of FI66880C publication Critical patent/FI66880C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FI802092A 1979-07-26 1980-07-01 Foerfarande foer framstaellning av ett terapeutiskt anvaendbart till 16alfa-metylpregnan-serien hoerande nytt halogenderivat FI66880C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7919296A FR2462443A1 (fr) 1979-07-26 1979-07-26 Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR7919296 1979-07-26

Publications (3)

Publication Number Publication Date
FI802092A FI802092A (fi) 1981-01-27
FI66880B FI66880B (fi) 1984-08-31
FI66880C true FI66880C (fi) 1984-12-10

Family

ID=9228325

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802092A FI66880C (fi) 1979-07-26 1980-07-01 Foerfarande foer framstaellning av ett terapeutiskt anvaendbart till 16alfa-metylpregnan-serien hoerande nytt halogenderivat

Country Status (20)

Country Link
US (1) US4353899A (es)
JP (1) JPS5622798A (es)
AT (1) AT371483B (es)
AU (1) AU528292B2 (es)
BE (1) BE884494A (es)
CA (1) CA1141751A (es)
CH (1) CH645389A5 (es)
DE (1) DE3028255C2 (es)
DK (1) DK146690C (es)
FI (1) FI66880C (es)
FR (1) FR2462443A1 (es)
GB (1) GB2054600B (es)
HU (1) HU180364B (es)
IE (1) IE50031B1 (es)
IT (1) IT1145302B (es)
MX (1) MX6649E (es)
NL (1) NL8004282A (es)
NO (1) NO153102C (es)
SE (1) SE447387B (es)
ZA (1) ZA803867B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments
FR2561919B1 (fr) * 1984-04-03 1986-12-19 Roussel Uclaf Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon
DE19932511A1 (de) * 1999-07-12 2001-01-18 Helmig Hans Gmbh Schaltvorrichtung für eine Kettengangschaltung zur Betätigung der Kettenradgruppe an der Tretkurbel eines Fahrrades

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122815C (es) * 1963-12-19
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
FR2381065A2 (fr) * 1977-02-22 1978-09-15 Roussel Uclaf Nouveaux derives halogenes de la serie du 16 a-methyl pregnane

Also Published As

Publication number Publication date
AT371483B (de) 1983-06-27
US4353899A (en) 1982-10-12
SE8004428L (sv) 1981-01-27
IE50031B1 (en) 1986-02-05
BE884494A (fr) 1981-01-26
FR2462443B1 (es) 1982-12-31
FI802092A (fi) 1981-01-27
DK146690B (da) 1983-12-05
ZA803867B (en) 1981-06-24
SE447387B (sv) 1986-11-10
IT1145302B (it) 1986-11-05
DE3028255C2 (de) 1985-12-19
CH645389A5 (fr) 1984-09-28
CA1141751A (fr) 1983-02-22
NO802256L (no) 1981-01-27
IT8049248A0 (it) 1980-07-15
IE801561L (en) 1981-01-26
DK321180A (da) 1981-01-27
AU6081180A (en) 1981-01-29
MX6649E (es) 1985-10-01
NO153102B (no) 1985-10-07
JPS5622798A (en) 1981-03-03
GB2054600A (en) 1981-02-18
FR2462443A1 (fr) 1981-02-13
ATA391380A (de) 1982-11-15
HU180364B (en) 1983-02-28
DE3028255A1 (de) 1981-02-19
NO153102C (no) 1986-01-15
NL8004282A (nl) 1981-01-28
DK146690C (da) 1984-05-21
GB2054600B (en) 1983-02-02
FI66880B (fi) 1984-08-31
AU528292B2 (en) 1983-04-21
JPS6254438B2 (es) 1987-11-14

Similar Documents

Publication Publication Date Title
EP0701565B1 (de) Neue prednisolonderivate
DE2912331A1 (de) Neue 17 beta -thiocarboxylate von 3-oxo-androst-4-en- bzw. -androsta-1,4-dienderivaten, ihre herstellung und diese enthaltende arzneimittel
PL118567B1 (en) Process for preparing novel esters of 4-halogen-3-ketoandrosteno-4-carbo-17 betha-thiolic acidosteno-4-karbotiolovojj-17 kisloty
FI66880C (fi) Foerfarande foer framstaellning av ett terapeutiskt anvaendbart till 16alfa-metylpregnan-serien hoerande nytt halogenderivat
CN101861327B (zh) 一种抗炎化合物的无定形形式
FI77668B (fi) Foerfarande foer framstaellning av nya 16 -metyl-pregnanseriens diklorderivat.
DE2954699C2 (es)
US5266566A (en) Method of treating fungal infections using sterodial ester compounds
DE2709078C2 (de) Neue Halogen-Derivate der Reihe des 16α-Methylpregnans, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
IE45877B1 (en) New derivatives of 9-chloroprednisolone
PL112152B1 (en) Process for preparing novel derivatives of 9-chloroprednisolone
US4264584A (en) Hydrocortisone orthoesters, pharmaceutical formulations thereof and processes for the preparation thereof
CS244662B2 (cs) Způsob výroby nových derivátů 9-chlorprednisolonu
HU181970B (en) Process for preparing new derivatives of 9alpha-fluoro-prednisolone
FI63422B (fi) Analogifoerfarande foer framstaellande av nya 21-salicylsyraestrar och 21-acetylsalicylsyraestrar av steroider ur pregnanserien
DE2256129B2 (de) desoxyprednisolon, Verfahren zur Herstellung derselben sowie diese enthaltende Arzneimittel
CS202593B2 (cs) Způsob výroby derivátů 9-fluorprednisolonu
CS244663B2 (cs) Způsob výroby nových derivátů 9-chlorprednisolonu
DE2818319A1 (de) Neue ester von 6-chlor-11beta,17alpha, 21-trihydroxypregna-1,4,6-trien-3,20-dion

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: ROUSSEL UCLAF SOCIETE ANONYME